Inflammatory syndrome with liver adenomatosis: The beneficial effects of surgical management [5]

Gut

Volumn 56, Issue 2, 2007, Pages 307-309

  Sa Cunha, A ^a   Blanc, J F ^a   Lazaro, E ^a   Mellottee, L ^b   Le Bail, B ^c   Zucman Rossi, J ^b   Balabaud, C ^c   Bioulac Sage, P ^c,d  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADENOMATOSIS; CLINICAL FEATURE; GENE MUTATION; HUMAN; INFLAMMATION; LETTER; LIVER FUNCTION TEST; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 33846992713     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.106245     Document Type: Letter

References (10)

1. Biouloc-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005;128:1211- 18.
2. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Biallelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002;32:312- 15.
3. Zucman-Rossi J, Jeannot E, Tran Van Nhieu J, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515-24.
4. Thysell H, Ingvar C, Gustafson T, et al. Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol 1986;2:450-7.
5. Fievet P, Sevestre H, Boudjelal M, et al. Systemic AA amyloidosis induced by liver cell adenoma. Gut 1990;31:361-3.
6. Berthet B, Escoffier JM, Weiller PJ, et al. Inflammatory syndrome, anicteric cholestasis and hepatic adenoma. J Chir (Paris) 1993;130:297-9.
7. Melin JP, Lecrique T, Wynckel A, et al. Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy. Nephron 1993;64:157-8.
8. Cosme A, Horcajada JP, Vidaur F, et al. Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. Liver 1995;15:164-7.
9. Shibasaki T, Matsumoto H, Watabe K, et al. A case of renal amyloidosis associated with hepatic adenoma: the pathogenetic role of tumor necrosis factor-alpha. Nephron 1997;75:350-3.
10. Delgado MA, Liu JY, Meleg-Smith S. Systemic amyloidosis associated with hepatocellular carcinoma. Case report and literature review. J La State Med Soc 1999;151:474-8.